ProCE Banner Activity

Interactive Decision Support Tool: Expert Guidance for the Treatment of Advanced HCC

Tool

Use this Interactive Decision Support Tool to compare your choices of therapy for patients with advanced HCC with those of 5 renowned experts.

Released: March 31, 2021

Expiration: March 30, 2022

No longer available for credit.

Share

Faculty

Richard Finn

Richard Finn, MD

Associate Professor of Medicine
Division of Hematology-Oncology
David Geffen School of Medicine at UCLA
Los Angeles, California

Thomas A. Abrams

Thomas A. Abrams, MD

Institute Physician
Director, Liver Tumor Center
Dana-Farber Cancer Institute
Boston, Massachusetts

Amit G. Singal

Amit G. Singal, MD, MS

Chief of Hepatology
Medical Director
, Liver Tumor Program
Professor, Department of Internal Medicine
UT Southwestern Medical Center
Dallas, Texas

Mark Yarchoan

Mark Yarchoan, MD

Assistant Professor
The Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins
Baltimore, Maryland

Andrew X. Zhu

Andrew X. Zhu, MD, PhD, FACP

Director, Liver Cancer Research
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Genentech, a member of the Roche Group

Lilly

Additional Information

Program Medium

This program has been made available online.